Hoseah M. Akala - Infectious Diseases

Author Information

Hoseah M. Akala is a distinguished researcher affiliated with the Department of Emerging and Infectious Diseases at the United States Army Medical Research Directorate-Africa, which is part of the Kenya Medical Research Institute/Walter Reed Project in Kisumu, Kenya. His work primarily focuses on infectious diseases, with a particular emphasis on malaria research.

Research Contributions

Hoseah M. Akala has made significant contributions to the field of infectious diseases, particularly in the study of malaria and other protozoan parasites. His research includes exploring new therapeutic targets, such as calcium homeostasis in parasites, and investigating the epidemiology and clinical implications of malaria and co-infections. He has also contributed to understanding drug resistance and interactions between different Plasmodium species. His work on natural compounds and their antiplasmodial activities highlights his interest in finding novel treatments for malaria.

Aliases

Hoseah M. Akala is known by several aliases including Hoseah Akala, Hosea M. Akala, Hosea M Akala, Hosea Akala, H Akala, H M Akala, and Hoseah M. Akala.

Publication and Citation Metrics

Metric	Value
Total Papers	99
Total Citations	1349
h-index	22

Publications:

A new C-C linked benzophenathridine-2-quinoline dimer, and the antiplasmodial activity of alkaloids from Zanthoxylum holstzianum.

DOI: 10.1080/14786419.2022.2034810

Year: 2022

The Multistage Antimalarial Compound Calxinin Modulates Calcium Homeostasis Targeting a Unique Calcium Channel Involved in Subcellular Calcium Storage in P. falciparum

DOI: 10.2139/ssrn.4002022

Year: 2022

The emerging paradigm of calcium homeostasis as a new therapeutic target for protozoan parasites

DOI: 10.1002/med.21804

Year: 2021

Hepatitis and tuberculosis testing are much less common than HIV testing among adults in Kisumu, Kenya: results from a cross-sectional assessment

DOI: 10.1186/s12889-021-11164-2

Year: 2021

A new benzophenone, and the antiplasmodial activities of the constituents of Securidaca longipedunculata fresen (Polygalaceae).

DOI: 10.1080/14786419.2021.1925272

Year: 2021

Epidemiological and clinical implications of asymptomatic malaria and schistosomiasis co-infections in a rural community in western Kenya

DOI: 10.1186/s12879-021-06626-2

Year: 2021

Synergism in Antiplasmodial Activities of Artemether and Lumefantrine in Combination with Securidaca longipedunculata Fresen (Polygalaceae)

DOI: 10.3390/plants11010047

Year: 2021

Plasmodium interspecies interactions during a period of increasing prevalence of Plasmodium ovale in symptomatic individuals seeking treatment: an observational study

DOI: 10.1016/S2666-5247(21)00009-4

Year: 2021

Longitudinal characterization of Plasmodium inter-species interactions during a period of increasing prevalence of Plasmodium ovale

DOI: 10.1101/2019.12.28.19015941

Year: 2020

A seven-year surveillance of epidemiology of malaria reveals travel and gender are the key drivers of dispersion of drug resistant genotypes in Kenya

DOI: 10.7717/peerj.8082

Year: 2020

What are T Cells?

How Can HIV/AIDS Be Prevented?

How Can Individuals Support CDC's Efforts?

Why are Chest CT Scans Important in Infectious Diseases?

What is Chronic Infection?

How is Botulism Transmitted?

How Does WHO Address Infectious Diseases?

What are the Objectives of the RBM Partnership?

What to Do If Infection is Suspected Post-Transfusion?

How Can Technology Help?

Partnered Content Networks

Relevant Topics